Adit EdTech Acquisition (ADEX) Competitors

$5.38
0.00 (0.00%)
(As of 05/16/2024 ET)

ADEX vs. NHIQ, LIFW, SY, ABIO, RMTI, DRIO, HCWB, APYX, EUDA, and XLO

Should you be buying Adit EdTech Acquisition stock or one of its competitors? The main competitors of Adit EdTech Acquisition include NantHealth (NHIQ), MSP Recovery (LIFW), So-Young International (SY), ARCA biopharma (ABIO), Rockwell Medical (RMTI), DarioHealth (DRIO), HCW Biologics (HCWB), Apyx Medical (APYX), EUDA Health (EUDA), and Xilio Therapeutics (XLO). These companies are all part of the "medical" sector.

Adit EdTech Acquisition vs.

NantHealth (NASDAQ:NHIQ) and Adit EdTech Acquisition (NYSE:ADEX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, community ranking, risk, profitability, valuation and earnings.

NantHealth has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500. Comparatively, Adit EdTech Acquisition has a beta of -0.34, meaning that its share price is 134% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NantHealth
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Adit EdTech Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Adit EdTech Acquisition's average media sentiment score of 0.00 equaled NantHealth'saverage media sentiment score.

Company Overall Sentiment
NantHealth Neutral
Adit EdTech Acquisition Neutral

Adit EdTech Acquisition has lower revenue, but higher earnings than NantHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NantHealth$67M0.35-$67.78MN/AN/A
Adit EdTech Acquisition$19.62M2.44-$18.66MN/AN/A

0.8% of Adit EdTech Acquisition shares are held by institutional investors. 61.3% of NantHealth shares are held by insiders. Comparatively, 0.3% of Adit EdTech Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Adit EdTech Acquisition has a net margin of 0.00% compared to Adit EdTech Acquisition's net margin of -109.49%.

Company Net Margins Return on Equity Return on Assets
NantHealth-109.49% N/A -38.79%
Adit EdTech Acquisition N/A N/A -63.62%

NantHealth and Adit EdTech Acquisition both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
NantHealthN/AN/A
Adit EdTech AcquisitionN/AN/A

Summary

NantHealth and Adit EdTech Acquisition tied by winning 4 of the 8 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADEX vs. The Competition

MetricAdit EdTech AcquisitionData processing & preparation IndustryMedical SectorNYSE Exchange
Market Cap$47.88M$3.58B$5.11B$18.12B
Dividend YieldN/A2.03%37.14%3.46%
P/E RatioN/A22.08170.9225.60
Price / Sales2.446.382,321.7110.81
Price / CashN/A46.1736.1519.66
Price / Book-0.807.185.476.07
Net Income-$18.66M$19.79M$105.14M$966.34M
7 Day PerformanceN/A0.73%2.43%1.48%
1 Month PerformanceN/A10.84%4.64%6.65%
1 Year Performance-48.37%3.62%7.18%21.87%

Adit EdTech Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NHIQ
NantHealth
0 of 5 stars
$1.50
+7.1%
N/AN/A$48.90M$67M0.00365
LIFW
MSP Recovery
1.1576 of 5 stars
$0.88
-0.7%
N/A-93.8%$123.19M$7.70M0.00100News Coverage
Gap Up
SY
So-Young International
0 of 5 stars
$1.30
flat
N/A-55.2%$128.52M$210.99M43.181,357
ABIO
ARCA biopharma
0 of 5 stars
$3.29
+2.2%
N/A+91.8%$47.74MN/A-7.834Analyst Forecast
RMTI
Rockwell Medical
3.8896 of 5 stars
$1.64
+1.9%
$7.00
+326.8%
-25.6%$48.15M$83.61M-4.10237Earnings Report
Analyst Forecast
News Coverage
DRIO
DarioHealth
2.2023 of 5 stars
$1.63
+1.9%
$5.37
+229.2%
-50.3%$48.36M$20.35M-1.58276News Coverage
HCWB
HCW Biologics
0 of 5 stars
$1.28
flat
N/A-25.9%$48.41M$2.84M-1.8345Short Interest ↑
APYX
Apyx Medical
4.0022 of 5 stars
$1.41
+0.7%
$6.17
+337.4%
-73.0%$48.84M$52.35M-2.61252Earnings Report
EUDA
EUDA Health
0 of 5 stars
$1.75
-7.4%
N/A+59.7%$46.55M$7.55M0.00150
XLO
Xilio Therapeutics
0.5519 of 5 stars
$1.26
+0.8%
N/A-65.6%$46.51MN/A-0.4573Short Interest ↑

Related Companies and Tools

This page (NYSE:ADEX) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners